Efficacy and safety of short-course blinatumomab in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia.
APA
Liu G, Zhou Y, et al. (2026). Efficacy and safety of short-course blinatumomab in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia.. Blood cancer journal, 16(1). https://doi.org/10.1038/s41408-026-01460-8
MLA
Liu G, et al.. "Efficacy and safety of short-course blinatumomab in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia.." Blood cancer journal, vol. 16, no. 1, 2026.
PMID
41851082
같은 제1저자의 인용 많은 논문 (5)
- m6A-Modified BASP1 Regulates IL6 Expression to Induce TAM Infiltration to Promote Gastric Cancer Progression.
- Real-world incidence, prevalence, and clinical impact of brain metastases in patients with ALK-positive metastatic non-small cell lung cancer treated with first-line ALK tyrosine kinase inhibitors.
- Effectiveness of the aspiration method in preventing delayed bleeding after gastric endoscopic submucosal dissection.
- Angiotensin‑converting enzyme 2 as an immune and prognostic biomarker in colorectal cancer.
- PSMA PET-guided intensification of postprostatectomy salvage radiotherapy for prostate cancer: a systematic review and meta-analysis.